Literature DB >> 9300693

Leukocyte function-associated antigen-1-dependent lysis of Fas+ (CD95+/Apo-1+) innocent bystanders by antigen-specific CD8+ CTL.

H Kojima1, K Eshima, H Takayama, M V Sitkovsky.   

Abstract

Exquisite specificity toward Ag-bearing cells (cognate targets) is one of the most important properties of CD8+ CTL-mediated cytotoxicity. Using highly Ag-specific CD8+ CTL lines and clones, which spare noncognate, Ag-free targets, we found that in the presence of Ag-bearing targets the CTL acquire the ability to lyse noncognate target cells (bystanders). It is shown that the unexpectedly rapid and efficient lysis of bystanders by Ag-activated CTL is mediated by a Fas ligand (FasL)/Fas-based mechanism and does not depend on perforin. The CTL lysed Fas-expressing bystanders, but spared the Fas-negative or anti-Fas mAb-resistant bystander cells. Accordingly, the FasL-deficient gld/gld CTL did not kill bystanders, while perforin-deficient CTL did. Unlike anti-Fas mAb-induced cell death, the lysis of bystanders was not only FasL/Fas dependent but also required adhesion molecule LFA-1 on the surface of the activated CTL. Lysis of bystanders is viewed as acceptable "collateral" damage, but the persistent presence of activated CTL could result in immunopathologies involving functional Fas-expressing tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300693

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Gallid Herpesvirus 1 Initiates Apoptosis in Uninfected Cells through Paracrine Repression of p53.

Authors:  Hai Li; Qi Gao; Yuhao Shao; Bangyao Sun; Fengjie Wang; Yangyang Qiao; Nana Wang; Shengwang Liu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy.

Authors:  Lillian Sun; Ellen Moore; Rose Berman; Paul E Clavijo; Anthony Saleh; Zhong Chen; Carter Van Waes; John Davies; Jay Friedman; Clint T Allen
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

Review 3.  Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.

Authors:  Michail Sitkovsky; Akio Ohta
Journal:  J Mol Med (Berl)       Date:  2013-01-20       Impact factor: 4.599

4.  Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing.

Authors:  Sandra L Ross; Marika Sherman; Patricia L McElroy; Julie A Lofgren; Gordon Moody; Patrick A Baeuerle; Angela Coxon; Tara Arvedson
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

5.  Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes.

Authors:  M J Smyth; E Krasovskis; R W Johnstone
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.